{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:07:04Z","timestamp":1776391624762,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ajo.2016.04.019","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T15:32:16Z","timestamp":1469201536000},"page":"249-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours"],"prefix":"10.1016","volume":"169","author":[{"given":"John H.K.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Slight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L.","family":"Vittitow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baldo","family":"Scassellati Sforzolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ajo.2016.04.019_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajo.2016.04.019_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1167\/iovs.02-0666","article-title":"Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes","volume":"44","author":"Liu","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2016.04.019_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1167\/iovs.12-10709","article-title":"Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension","volume":"54","author":"Grippo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2016.04.019_bib4","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"Orzalesi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2016.04.019_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ajo.2006.01.049","article-title":"Sustained effect of travoprost on diurnal and nocturnal intraocular pressure","volume":"141","author":"Sit","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2016.04.019_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ophtha.2005.10.045","article-title":"Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"113","author":"Orzalesi","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2016.04.019_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ophtha.2008.09.054","article-title":"Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy","volume":"116","author":"Liu","year":"2009","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2016.04.019_bib9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ophtha.2010.03.026","article-title":"Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure","volume":"117","author":"Liu","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2016.04.019_bib10","doi-asserted-by":"crossref","first-page":"e001106","DOI":"10.1136\/bmjopen-2012-001106","article-title":"Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure","volume":"2","author":"Tung","year":"2012","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ajo.2016.04.019_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.exer.2011.03.001","article-title":"Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2\u03b1 agonist, in preclinical models","volume":"93","author":"Krauss","year":"2011","journal-title":"Exp Eye Res"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2016.04.019_bib12","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"Toris","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.04.019_bib13","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1167\/iovs.12-9483m","article-title":"Advances in glaucoma treatment and management: outflow drugs","volume":"53","author":"Kaufman","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2016.04.019_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-3565(25)11469-9","article-title":"Nitrovasodilators as a new class of ocular hypotensive agents","volume":"260","author":"Nathanson","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.ajo.2016.04.019_bib15","first-page":"1774","article-title":"Alterations of ocular nitric oxide synthase in human glaucoma","volume":"36","author":"Nathanson","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2016.04.019_bib16","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1167\/iovs.14-14515","article-title":"Nitric oxide (NO): an emerging target for the treatment of glaucoma","volume":"55","author":"Cavet","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib17","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1167\/iovs.14-16015","article-title":"Regulation of endothelin-1-induced trabecular meshwork cell contractility by latanoprostene bunod","volume":"56","author":"Cavet","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2016.04.019_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-120-3-199402010-00009","article-title":"Nitric oxide: a physiologic messenger","volume":"120","author":"Lowenstein","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bjophthalmol-2014-305908","article-title":"A randomized, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study","volume":"99","author":"Weinreb","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2016.04.019_bib20","first-page":"2912","article-title":"Twenty-four-hour pattern of intraocular pressure in the aging population","volume":"40","author":"Liu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2016.04.019_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaophthalmol.2014.1761","article-title":"Hourly awakening vs continuous contact lens sensor measurements of 24-hour intraocular pressure. Effect on sleep macrostructure and intraocular pressure rhythm","volume":"132","author":"Aptel","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib22","doi-asserted-by":"crossref","first-page":"e0129529","DOI":"10.1371\/journal.pone.0129529","article-title":"Estimation of 24-hour intraocular pressure peak timing and variation using a contact lens sensor","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2016.04.019_bib23","series-title":"Glaucoma: Conceptions of a Disease, Pathogenesis, Diagnosis, Therapy","first-page":"97","article-title":"Physiological aspects of the circulation in the optic nerve","author":"Bill","year":"1978"},{"issue":"4","key":"10.1016\/j.ajo.2016.04.019_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/108076803322279354","article-title":"Laboratory assessment of diurnal and nocturnal ocular perfusion pressures in humans","volume":"19","author":"Liu","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2016.04.019_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2010.01.018","article-title":"The Blood Flow in Glaucoma Discussion Group. Blood pressure, perfusion pressure, and glaucoma","volume":"149","author":"Caprioli","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2016.04.019_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2012.05.003","article-title":"24-hour intraocular pressure and ocular perfusion pressure in glaucoma","volume":"58","author":"Quaranta","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.04.019_bib27","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1111\/aos.12298","article-title":"Ocular perfusion pressure in glaucoma","volume":"92","author":"Costa","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2016.04.019_bib28","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.ophtha.2010.06.017","article-title":"Assessing the effectiveness of intraocular pressure-lowering therapy","volume":"117","author":"Realini","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjo.2003.028357","article-title":"Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma","volume":"88","author":"Galassi","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.04.019_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archophthalmol.2011.2573","article-title":"Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy","volume":"130","author":"Gulati","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.04.019_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2016.01.019","article-title":"Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension","volume":"123","author":"Weinreb","year":"2016","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416301945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416301945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:32:54Z","timestamp":1757597574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939416301945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":31,"alternative-id":["S0002939416301945"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2016.04.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2016.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}